Cargando…
Looking ahead: where to next for animal models of bronchopulmonary dysplasia?
Bronchopulmonary dysplasia (BPD) is the most common complication of preterm birth, with appreciable morbidity and mortality in a neonatal intensive care setting. Much interest has been shown in the identification of pathogenic pathways that are amenable to pharmacological manipulation (1) to facilit...
Autores principales: | Nardiello, Claudio, Mižíková, Ivana, Morty, Rory E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320021/ https://www.ncbi.nlm.nih.gov/pubmed/27917436 http://dx.doi.org/10.1007/s00441-016-2534-3 |
Ejemplares similares
-
The Extracellular Matrix in Bronchopulmonary Dysplasia: Target and Source
por: Mižíková, Ivana, et al.
Publicado: (2015) -
Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia
por: Nardiello, Claudio, et al.
Publicado: (2017) -
MicroRNA in late lung development and bronchopulmonary dysplasia: the need to demonstrate causality
por: Nardiello, Claudio, et al.
Publicado: (2016) -
Targeting miR‐34a/Pdgfra interactions partially corrects alveologenesis in experimental bronchopulmonary dysplasia
por: Ruiz‐Camp, Jordi, et al.
Publicado: (2019) -
Perinatal origins of bronchopulmonary dysplasia—deciphering normal and impaired lung development cell by cell
por: Mižíková, I., et al.
Publicado: (2023)